Single cell analysis using CyTOF demonstrated that DLBCL tumor cells are phenotypically unique to each patient, with a small number of samples displaying distinct sub-clonal structures, often distinguished by the differential expression of immune-related proteins such as MHC-II rather than GCB vs. ABC [41]. This evidence concerns the gene ABCB6 and diffuse large B-cell lymphoma.